New ACC research: a gene marker, a global care review, and a French study.
Here is what is new for adrenocortical carcinoma patients and caregivers.
🧬 AKR1B1 Gene Study
Researchers found that the AKR1B1 gene (a protein involved in stress response) helps predict survival in ACC.
High levels of this gene are linked to worse outcomes and lower sensitivity to immunotherapy.
This could help doctors choose better treatments based on your tumor's specific biology.
🌎 Global Care Review
A new review compares how ACC is treated across the Americas.
It shows that US centers often have better access to specialized care and structured pathways.
This highlights the importance of seeking care at high-volume centers for the best outcomes.
🇫🇷 Strasbourg Cohort Study
A trial run by the University Hospital in Strasbourg (France) is currently recruiting.
It studies the natural history of ACC to improve patient management.
This observational study helps doctors understand how the disease progresses over time.
#AdrenocorticalCarcinoma #ACCResearch #CancerCare #MedicalUpdates
AI-generated; for informational purposes only, not medical advice